Tavneos 10 MG capsule 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FM8J4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,768
Award facts
- Contract value 100% obligated
- $10,768.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,768.37 to AmerisourceBergen Drug Corp for the supply of TAVNEOS (cephalexin) 10 mg capsules (180-count package) on December 30, 2025, with completion targeted for January 22, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work from its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for TAVNEOS capsules exemplifies the company's role in supporting federal healthcare requirements through firm fixed-price transactions under its master IDC vehicle, which enables flexible global pharmaceutical support for defense and federal health programs.
Quick answers
Who was awarded contract SPE2DR26FM8J4?
SPE2DR26FM8J4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FM8J4 worth?
The government has obligated $10,768 on SPE2DR26FM8J4.
Is contract SPE2DR26FM8J4 an order under another contract?
Yes. SPE2DR26FM8J4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8J4 competed?
The extent of competition for SPE2DR26FM8J4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award